PRESTONCT07938567
Preeclampsia Screening Trial to Improve Outcomes
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Secondary (8)
Show 3 moreShow less
Arms and interventions
Patients will be enrolled upon admission to the Labor \& Delivery/Maternity or antepartum units. Triage units will be considered part of Labor \& Delivery for this study. Management proceeds per local standard of care. Blood samples for sFlt-1/PlGF measurement will be collected and stored for later analysis; however, test results will remain blinded to clinicians and will not be available to guide clinical management during this phase. Biomarker measurements will be analyzed retrospectively for research purposes.
Patients will be enrolled upon admission to the Labor \& Delivery/Maternity or antepartum units. Triage units will be considered part of Labor \& Delivery for this study. During the Intervention phase (post-implementation), results are reported in real time (within 24 hours) to treating clinicians. Management proceeds per the treating clinician, who has been educated to use the FDA-approved algorithm for the use of the test.
Devices: Kryptor sFlt-1/PlGF assays on serum/plasma
Other: Treatment
Sites
1 site in 1 country
- Emory Decatur HospitalDecatur, Georgia, United States